CRISPR/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6

por Yoshiba, Takahiro, Saga, Yasushi, Urabe, Masashi, Uchibori, Ryosuke, Matsubara, Shigeki, Fujiwara, Hiroyuki, Mizukami, Hiroaki
Publicado 2019

Durable response after the discontinuation of pembrolizumab treatment due to an adverse event in a patient with advanced endometrial cancer: A case report

por Umihira, Shuntaro, Koyanagi, Takahiro, Tamura, Kohei, Takahashi, Yoshifumi, Yoshiba, Takahiro, Takahashi, Suzuyo, Taneichi, Akiyo, Saga, Yasushi, Takei, Yuji, Fujiwara, Hiroyuki
Publicado 2022

Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer

por Koyanagi, Takahiro, Saga, Yasushi, Takahashi, Yoshifumi, Tamura, Kohei, Yoshiba, Takahiro, Takahashi, Suzuyo, Taneichi, Akiyo, Takei, Yuji, Urabe, Masashi, Mizukami, Hiroaki, Fujiwara, Hiroyuki
Publicado 2021